Leopold WR 3rd - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Preclinical antitumor activity of CI-994.

LoRusso PM, Demchik L, Foster B, Knight J, Bissery MC, Polin LM, Leopold WR 3rd, Corbett TH. LoRusso PM, et al. Among authors: leopold wr 3rd. Invest New Drugs. 1996;14(4):349-56. doi: 10.1007/BF00180810. Invest New Drugs. 1996. PMID: 9157069

Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.

Elliott WL, Roberts BJ, Howard CT, Leopold WR 3rd. Elliott WL, et al. Among authors: leopold wr 3rd. Cancer Res. 1994 Aug 15;54(16):4412-8. Cancer Res. 1994. PMID: 8044790

In vivo and in vitro evaluation of the alkylating agent carmethizole.

Elliott WL, Fry DW, Anderson WK, Nelson JM, Hook KE, Hawkins PA, Leopold WR 3rd. Elliott WL, et al. Among authors: leopold wr 3rd. Cancer Res. 1991 Sep 1;51(17):4581-7. Cancer Res. 1991. PMID: 1873802

Experimental antitumor activity of the amsacrine analogue CI-921.

Leopold WR 3rd, Corbett TH, Griswold DP Jr, Plowman J, Baguley BC. Leopold WR 3rd, et al. J Natl Cancer Inst. 1987 Aug;79(2):343-9. J Natl Cancer Inst. 1987. PMID: 3474465

Pyrazole derivatives. 5. Synthesis and antineoplastic activity of 3-(2-chloroethyl)-3,4-dihydro-4-oxopyrazolo[5,1-d]-1,2,3, 5-tetrazine-8-carboxamide and related compounds.

Cheng CC, Elslager EF, Werbel LM, Priebe SR, Leopold WR 3rd. Cheng CC, et al. Among authors: leopold wr 3rd. J Med Chem. 1986 Aug;29(8):1544-7. doi: 10.1021/jm00158a041. J Med Chem. 1986. PMID: 3735323

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5 results

Search Page

Filters